Abstract
Molybdenum cofactor deficiency (MoCoD) is a fatal disorder manifesting, shortly after birth, with profound neurological abnormalities, mental retardation, and severe seizures unresponsive to any therapy. The disease is a monogenic, autosomal recessive disorder, and the existence of at least two complementation groups suggests genetic heterogeneity. In humans, MoCoD leads to the combined deficient activities of sulfite oxidase, xanthine dehydrogenase, and aldehyde oxidase. By using homozygosity mapping and two consanguineous affected kindreds of Israeli-Arab origin, including five patients, we demonstrated linkage of a MoCoD gene to an 8-cM region on chromosome 6p21.3, between markers D6S1641 and D6S1672. Linkage analysis generated the highest combined LOD-score value, 3.6, at a recombination fraction of 0, with marker D6S1575. These results now can be used to perform prenatal diagnosis with microsatellite markers. They also provide the only tool for carrier detection of this fatal disorder.
Original language | English |
---|---|
Pages (from-to) | 148-154 |
Number of pages | 7 |
Journal | American Journal of Human Genetics |
Volume | 63 |
Issue number | 1 |
DOIs | |
State | Published - Jul 1998 |
Externally published | Yes |
Bibliographical note
Funding Information:This work was supported by the Israel Ministry of Health (to N.C. and H.M.) and by the Joseph Alias Fund for Medical Research (to H.M.). A.S. was supported, in part, by a fellowship from the Galilee Society (the Arab National Society for Health Research and Services). We thank members of the Généthon laboratory, including Arnaud Lemainque, Sabine Fauré, Claire Rochette, and Maud Petit, for their assistance with initial genomic screening. The collaboration of the families is gratefully acknowledged.
Funding
This work was supported by the Israel Ministry of Health (to N.C. and H.M.) and by the Joseph Alias Fund for Medical Research (to H.M.). A.S. was supported, in part, by a fellowship from the Galilee Society (the Arab National Society for Health Research and Services). We thank members of the Généthon laboratory, including Arnaud Lemainque, Sabine Fauré, Claire Rochette, and Maud Petit, for their assistance with initial genomic screening. The collaboration of the families is gratefully acknowledged.
Funders | Funder number |
---|---|
Arab National Society for Health Research and Services | |
Galilee Society | |
Israel Ministry of Health | |
Joseph Alias Fund for Medical Research |